We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCBK icon
1501
TriCo Bancshares
TCBK
$1.84B
$851K ﹤0.01%
19,485
+1,066
+6% +$48.5K
TALO icon
1502
Talos Energy
TALO
$2.58B
$851K ﹤0.01%
87,672
+2,167
+3% +$22.8K
NIC icon
1503
Nicolet Bankshares
NIC
$3.72B
$850K ﹤0.01%
8,101
+442
+6% +$46.7K
VRDN icon
1504
Viridian Therapeutics
VRDN
$2.49B
$849K ﹤0.01%
44,295
+7,914
+22% +$172K
STEL
1505
DELISTED
Stellar Bancorp
STEL
$843K ﹤0.01%
29,733
+1,927
+7% +$54.9K
LOB icon
1506
Live Oak Bancshares
LOB
$1.98B
$836K ﹤0.01%
21,135
+1,169
+6% +$52.6K
SABR icon
1507
Sabre
SABR
$831M
$835K ﹤0.01%
228,843
+32,574
+17% +$119K
TGI
1508
DELISTED
Triumph Group
TGI
$834K ﹤0.01%
44,721
+3,941
+10% +$65.5K
PZZA icon
1509
Papa John's
PZZA
$793M
$834K ﹤0.01%
20,318
+1,125
+6% +$55.3K
DNOW icon
1510
DNOW Inc
DNOW
$3.04B
$834K ﹤0.01%
64,075
+4,061
+7% +$54.7K
CGON icon
1511
CG Oncology
CGON
$6.62B
$832K ﹤0.01%
29,026
+1,894
+7% +$64.8K
SCL icon
1512
Stepan Co
SCL
$1.48B
$832K ﹤0.01%
12,865
+528
+4% +$39.1K
WGO icon
1513
Winnebago Industries
WGO
$915M
$831K ﹤0.01%
17,383
+855
+5% +$48.4K
ASTH icon
1514
Astrana Health
ASTH
$1.78B
$829K ﹤0.01%
26,284
+1,173
+5% +$55.7K
VRE
1515
DELISTED
Veris Residential
VRE
$828K ﹤0.01%
49,810
+2,537
+5% +$44.2K
ALEX
1516
DELISTED
Alexander & Baldwin
ALEX
$828K ﹤0.01%
46,677
+2,175
+5% +$41K
HELE icon
1517
Helen of Troy
HELE
$696M
$826K ﹤0.01%
13,807
+787
+6% +$52.3K
PRAX icon
1518
Praxis Precision Medicines
PRAX
$10.8B
$822K ﹤0.01%
10,675
+544
+5% +$39.4K
WABC icon
1519
Westamerica Bancorp
WABC
$1.38B
$819K ﹤0.01%
15,607
+856
+6% +$45.8K
JBGS
1520
JBG SMITH
JBGS
$691M
$818K ﹤0.01%
53,216
+3,116
+6% +$52.2K
ESLT icon
1521
Elbit Systems
ESLT
$36.5B
$818K ﹤0.01%
3,126
+725
+30% +$170K
NHC icon
1522
National Healthcare
NHC
$3.47B
$817K ﹤0.01%
7,598
+436
+6% +$53K
USPH icon
1523
US Physical Therapy
USPH
$1.22B
$816K ﹤0.01%
9,194
+504
+6% +$44.9K
ZUO
1524
DELISTED
Zuora, Inc.
ZUO
$814K ﹤0.01%
82,012
+5,139
+7% +$49.9K
HTH icon
1525
Hilltop Holdings
HTH
$2.25B
$812K ﹤0.01%
28,369
+1,556
+6% +$48.6K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.